Recommendations to Reduce the Risk of Occupational
HIV Transmission After an Exposure Incident

Resources for Consultation

Clinicians can seek consultation on HIV/PEP from local experts.  In addition, the following resources are available.

• PEPline; telephone 888-448-4911;
  
  
• HIV Antiretroviral Pregnancy Registry at http://www.apregistry.com/index.htm; Address: Research Park, 1011 Ashes Drive, Wilmington, NC 28405. Telephone: 800-258-4263; Fax: 800-800-1052; E-mail: registry@nc.crl.com;
  
  
• FDA (for reporting unusual or severe toxicity to antiretroviral agents) at http://www.fda.gov/medwatch; telephone: 800-332-1088; address: MedWatch, HF-2, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857;
  
  
• CDC (for reporting HIV infections in HCP and failures of PEP) at telephone 800-893-0485; and
  
  
• HIV/AIDS Treatment Information Service at http://aidsinfo.nih.gov.
  
  

References

• Centers for Disease Control and Prevention.  Surveillance of Healthcare
  Personnel with HIV/AIDS, as of December 2002.  http://www.cdc.gov/ncidod/dhqp/bp_hiv_hp_with.html
  
  
• Occupational Safety and Health Administration (OSHA).  Occupational Exposure to Bloodborne Pathogens (29 CFR 1910.1030).  www.osha.gov
  
  
• Tokars, JI, Marcus, R, Culver, DH, et al.  Surveillance of HIV Infection and zidovudine use among healthcare workers after occupational exposure to HIV infected blood.  Ann Intern Med.  1993:118:913-919.
  
  
• Centers for Disease Control and Prevention.  Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Post-Exposure Prophylaxis.  MMWR 2005:54 (No. RR-09): 1-17. http://www.cdc.gov/mmwr/PDF/rr/rr5409.pdf
  
  
• Cardo, DM, Culver, DH, Cieselski, CA, et al.  A case-control study of HIV seroconversion in healthcare workers after percutaneous exposure.  N Engl J. Med. 97: 337:1485-1490.